This brand name is authorized in Canada.
The drug MYRBETRIQ contains one active pharmaceutical ingredient (API):
1
|
UNII
MVR3JL3B2V - MIRABEGRON
|
|
Mirabegron is a potent and selective beta3-adrenoceptor agonist. Mirabegron enhances urine storage function by stimulating beta3-adrenoceptors in the bladder. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| G04BD | Urinary antispasmodics | G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| CA | Health Products and Food Branch | 02402874, 02402882 |
| US | FDA, National Drug Code | 0469-2601, 0469-2602, 55154-8712, 55154-8713, 70518-2435 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.